The Recall Desk
ModerateFDA (Devices)·Z-2086-2026·Announced 2026-05-13

Uric Acid in vitro diagnostic test distributed without FDA clearance

DFI Co., Ltd. is recalling its Uric Acid in vitro diagnostic test (REF: 31H0P) because the devices were distributed without required FDA premarket clearance or approval.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is an FDA Class II device recall for distribution without premarket clearance. No illnesses, injuries, or device malfunctions are reported in the source text; the issue is regulatory compliance. Class II recalls without reported adverse events typically fall in the Moderate range per the rubric.

Plain-English summary

DFI Co., Ltd. is recalling the Uric Acid in vitro diagnostic test (REF: 31H0P) distributed in the United States, including Florida, Pennsylvania, and England. The devices were distributed without required FDA premarket clearance or approval.

The recalled lot numbers are 241023, 250415, 250509, 250617, and 250905. A total of 59,815 units have been distributed.

Consumers and healthcare providers who have these devices should contact DFI Co., Ltd. for further instructions on how to return or manage the recalled products. Laboratories using this test should cease using the recalled lots immediately.

The recalled product

Product
Uric Acid in vitro diagnostic test REF: 31H0P
Manufacturer
DFI Co., Ltd.
Hazard
  • unauthorized-distribution
  • lack-of-premarket-clearance

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (5)

  • UDI: 08806141303077/ Lot: 241023
  • 250415
  • 250509
  • 250617
  • 250905

Distribution

Distributed nationwide across the United States.